Physician

Nana Yaw Asamoah-Mensah, M.D.

According to 2025 Medicare claims, Nana Asamoah-Mensah, M.D. (NPI: 1023103587) practices neurology in the Washington, DC-MD market, with the plurality of this provider's patient population coming from The District, DC. This provider's primary affiliated billing organization is NANA YAW ASAMOAH-MENSAH, M.D.,P.C. (NPI: 1457666000) and primary practice location at 20017-2153.

Asamoah-Mensah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 384 traditional Medicare patients, billed 4,002 HCPCS/CPT codes, and received $349,790 in Medicare payments. The top billing code was 95816 (Measurement of brain wave activity (eeg), awake and drowsy). Part D data shows 1,071 prescription claims across 200 beneficiaries totaling $174,011 in drug costs, led by Aptiom (Eslicarbazepine Acetate). 2016 DME data shows 12 claims. Open Payments data shows 13 records totaling $240. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $527,285 and ending at $349,790. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	602	4,403	$527,285
2016	572	4,923	$593,394
2017	503	4,505	$518,994
2018	548	5,252	$603,893
2019	474	5,948	$670,430
2020	434	4,789	$416,794
2021	449	6,373	$644,201
2022	456	5,593	$495,946
2023	399	4,060	$391,679
2024	384	4,002	$349,790

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	182	1,046	$179,594
2016	163	992	$204,266
2017	151	802	$166,991
2018	164	885	$145,942
2019	155	965	$146,073
2020	143	826	$91,827
2021	138	851	$131,410
2022	144	886	$111,410
2023	163	955	$167,045
2024	200	1,071	$174,011

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	17	17	$1,247
2016	12	12	$1,020
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
95816	Measurement of brain wave activity (eeg), awake and drowsy	88	91	$325
93880	Ultrasound of both sides of head and neck blood flow	85	87	$156
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	86	101	$101
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	263	1,089	$93
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	95	2,315	$61

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Aptiom	Eslicarbazepine Acetate	18	539	$33,362
Glatopa	Glatiramer Acetate	11	308	$26,473
Pregabalin	Pregabalin	139	8,244	$13,298
Lacosamide	Lacosamide	38	1,668	$6,857
Levetiracetam	Levetiracetam	119	7,711	$4,164

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	13	$240	Sumitomo Pharma America, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Nana Yaw Asamoah-Mensah, M.D.?

Tedicare shows public-source Medicare data for Nana Yaw Asamoah-Mensah, M.D. (NPI 1023103587), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Nana Yaw Asamoah-Mensah, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Nana Yaw Asamoah-Mensah, M.D.?

Nana Yaw Asamoah-Mensah, M.D. is linked to NANA YAW ASAMOAH-MENSAH, M.D.,P.C. (billing NPI 1457666000) in the available physician profile data.

Does Nana Yaw Asamoah-Mensah, M.D. have Open Payments data?

Nana Yaw Asamoah-Mensah, M.D. has 13 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.